$DCTH
Delcath Systems Inc

2017 Q3 Form 10-Q Financial Statement

#000156459017023836 Filed on November 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q4 2016 Q3
Revenue $684.0K $676.0K $435.0K
YoY Change 57.24% 53.64% 8.75%
Cost Of Revenue $170.0K $180.0K $110.0K
YoY Change 54.55% 80.0% 22.22%
Gross Profit $510.0K $500.0K $320.0K
YoY Change 59.38% 47.06% 3.23%
Gross Profit Margin 74.56% 73.96% 73.56%
Selling, General & Admin $2.860M $2.410M $2.360M
YoY Change 21.19% 10.05% 3.51%
% of Gross Profit 560.78% 482.0% 737.5%
Research & Development $2.280M $2.470M $2.690M
YoY Change -15.24% 4.22% 60.12%
% of Gross Profit 447.06% 494.0% 840.63%
Depreciation & Amortization $100.0K $80.00K $100.0K
YoY Change 0.0% -33.33% 0.0%
% of Gross Profit 19.61% 16.0% 31.25%
Operating Expenses $5.139M $4.882M $5.047M
YoY Change 1.82% 6.83% 27.45%
Operating Profit -$4.627M -$4.383M -$4.724M
YoY Change -2.05% 3.64% 29.42%
Interest Expense $5.042M $10.21M $4.963M
YoY Change 1.59% -1315.48% -35550.0%
% of Operating Profit
Other Income/Expense, Net -$2.000K -$14.31M $3.000K
YoY Change -166.67% 71450.0% -127.27%
Pretax Income -$12.60M -$8.490M -$1.010M
YoY Change 1147.52% 66.8% -58.26%
Income Tax
% Of Pretax Income
Net Earnings -$12.60M -$8.486M -$1.004M
YoY Change 1154.58% 66.56% -58.55%
Net Earnings / Revenue -1841.52% -1255.33% -230.8%
Basic Earnings Per Share -$4.565K -$1.292K -$231.00
Diluted Earnings Per Share -$4.565K -$446900B -$80790B
COMMON SHARES
Basic Shares Outstanding 2.763K 2.197M
Diluted Shares Outstanding 2.763K

Balance Sheet

Concept 2017 Q3 2016 Q4 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.500M $4.410M $3.690M
YoY Change -32.25% -65.03% -77.86%
Cash & Equivalents $10.86M $4.409M $3.689M
Short-Term Investments
Other Short-Term Assets $9.220M $28.68M $24.54M
YoY Change -62.43% 2887.5% 3618.18%
Inventory $1.160M $660.0K $600.0K
Prepaid Expenses
Receivables $300.0K $403.0K $340.0K
Other Receivables $50.00K $0.00 $0.00
Total Short-Term Assets $13.23M $34.16M $29.17M
YoY Change -54.65% 133.93% 60.54%
LONG-TERM ASSETS
Property, Plant & Equipment $1.250M $1.083M $1.140M
YoY Change 9.65% -4.33% -18.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.670M
YoY Change
Total Long-Term Assets $1.260M $1.083M $7.810M
YoY Change -83.87% -4.33% 457.86%
TOTAL ASSETS
Total Short-Term Assets $13.23M $34.16M $29.17M
Total Long-Term Assets $1.260M $1.083M $7.810M
Total Assets $14.49M $35.24M $36.98M
YoY Change -60.82% 123.98% 88.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.890M $594.0K $180.0K
YoY Change 950.0% 109.15% -18.18%
Accrued Expenses $2.350M $3.407M $1.920M
YoY Change 22.4% 51.89% -3.52%
Deferred Revenue
YoY Change
Short-Term Debt $490.0K $0.00 $0.00
YoY Change
Long-Term Debt Due $9.740M $13.34M
YoY Change
Total Short-Term Liabilities $15.89M $36.10M $25.39M
YoY Change -37.42% 471.85% 390.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $6.410M
YoY Change -100.0%
Other Long-Term Liabilities $444.0K $604.0K $700.0K
YoY Change -36.57% -26.34% -19.54%
Total Long-Term Liabilities $444.0K $604.0K $7.110M
YoY Change -93.76% -26.34% 717.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.89M $36.10M $25.39M
Total Long-Term Liabilities $444.0K $604.0K $7.110M
Total Liabilities $16.34M $36.73M $32.49M
YoY Change -49.72% 414.99% 437.02%
SHAREHOLDERS EQUITY
Retained Earnings -$305.6M -$279.2M
YoY Change 6.88%
Common Stock $14.00K $0.00
YoY Change -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K $51.00K
YoY Change 0.0%
Treasury Stock Shares $1.00 $1.00
Shareholders Equity -$1.850M -$1.490M $4.490M
YoY Change
Total Liabilities & Shareholders Equity $14.49M $35.24M $36.98M
YoY Change -60.83% 123.98% 88.96%

Cashflow Statement

Concept 2017 Q3 2016 Q4 2016 Q3
OPERATING ACTIVITIES
Net Income -$12.60M -$8.486M -$1.004M
YoY Change 1154.58% 66.56% -58.55%
Depreciation, Depletion And Amortization $100.0K $80.00K $100.0K
YoY Change 0.0% -33.33% 0.0%
Cash From Operating Activities -$3.520M -$3.610M -$3.630M
YoY Change -3.03% -14.66% 12.38%
INVESTING ACTIVITIES
Capital Expenditures -$90.00K -$10.00K -$150.0K
YoY Change -40.0% -75.0% 275.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$30.00K
YoY Change -100.0%
Cash From Investing Activities -$90.00K -$20.00K -$170.0K
YoY Change -47.06% -114.29% 325.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -14.70M 4.470M -90.00K
YoY Change 16233.33% -44800.0% -101.5%
NET CHANGE
Cash From Operating Activities -3.520M -3.610M -3.630M
Cash From Investing Activities -90.00K -20.00K -170.0K
Cash From Financing Activities -14.70M 4.470M -90.00K
Net Change In Cash -18.31M 840.0K -3.890M
YoY Change 370.69% -120.49% -241.97%
FREE CASH FLOW
Cash From Operating Activities -$3.520M -$3.610M -$3.630M
Capital Expenditures -$90.00K -$10.00K -$150.0K
Free Cash Flow -$3.430M -$3.600M -$3.480M
YoY Change -1.44% -14.08% 9.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 dcth Preferred Stock Redemption Amount Current
PreferredStockRedemptionAmountCurrent
494000
CY2016Q4 dcth Preferred Stock Redemption Amount Current
PreferredStockRedemptionAmountCurrent
0
CY2017Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
30000
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
444000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
604000
CY2017Q3 us-gaap Liabilities
Liabilities
16336000
CY2016Q4 us-gaap Liabilities
Liabilities
36729000
CY2017Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15000
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-276000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-610000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
94000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
94000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
338000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-190000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1767000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
312000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
372000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
245000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-279188000
CY2017Q3 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
14000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
303808000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
277790000
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-305587000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
-1850000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-1490000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14486000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35239000
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1426153
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11805
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1425862
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11750
CY2017Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1
CY2016Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0625
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
7901000
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
0
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15000
us-gaap Net Income Loss
NetIncomeLoss
-25873000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000
us-gaap Net Income Loss
NetIncomeLoss
-9485000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25866000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9497000
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1132000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
933000
CY2017Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2016Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9613000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2017Q3 dcth Loss On Debt Settlement
LossOnDebtSettlement
2952000
dcth Loss On Debt Settlement
LossOnDebtSettlement
2952000
CY2017Q3 us-gaap Interest Expense
InterestExpense
5042000
CY2016Q3 us-gaap Interest Expense
InterestExpense
4963000
us-gaap Interest Expense
InterestExpense
20324000
us-gaap Interest Expense
InterestExpense
6584000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-12596000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-1004000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
286000
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
544000
CY2017Q3 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12611000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1006000
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-9.36
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-230.99
us-gaap Restricted Stock Expense
RestrictedStockExpense
228000
us-gaap Depreciation
Depreciation
198000
us-gaap Depreciation
Depreciation
232000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-11659000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10597000
us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
0
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-34.99
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2232.30
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
84000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
25866000
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
526000
dcth Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
15000
dcth Fair Value Of Warrants Exercised
FairValueOfWarrantsExercised
19000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
48000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
138000
us-gaap Restricted Stock Expense
RestrictedStockExpense
84000
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1401413
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4349
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
754421
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-20000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000
dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
-16000
dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
1000
dcth Deferred Revenues
DeferredRevenues
-30000
dcth Deferred Revenues
DeferredRevenues
31000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
20315000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6567000
dcth Loss On Debt Settlement
LossOnDebtSettlement
0
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-160000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-155000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4249
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
48000
us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
1087000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-372000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1332000
dcth Increase In Restricted Cash From Financing Activities
IncreaseInRestrictedCashFromFinancingActivities
0
dcth Increase In Restricted Cash From Financing Activities
IncreaseInRestrictedCashFromFinancingActivities
29200000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2278000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
31436000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
15000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
704000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10194000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2940000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-77000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
71000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1914000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8918000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12607000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3689000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
26199000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
28133000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
19000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
245000
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
70.00
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
49.00
CY2017Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
328000
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
346000
CY2017Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
660000
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
214000
CY2017Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
176000
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
100000
CY2017Q3 us-gaap Prepaid Insurance
PrepaidInsurance
61000
CY2016Q4 us-gaap Prepaid Insurance
PrepaidInsurance
501000
CY2017Q3 us-gaap Prepaid Taxes
PrepaidTaxes
53000
CY2017Q3 us-gaap Security Deposit
SecurityDeposit
50000
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
50000
CY2017Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
221000
CY2016Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
147000
CY2017Q3 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2016Q4 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5023000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4886000
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3770000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3803000
CY2017Q3 us-gaap Depreciation
Depreciation
100000
CY2016Q3 us-gaap Depreciation
Depreciation
100000
CY2017Q3 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
1410000
CY2016Q4 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
1365000
CY2017Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
448000
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
38.50
CY2017Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
21.00
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
544000
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
3045817
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
126000
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
4417830
CY2017Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
3621286
CY2017Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1913915
CY2017Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
2000000
CY2017Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
221000
CY2016Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
216000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
607000
CY2016Q4 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
126.00
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
112.00
CY2017Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
24.50
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1478318
CY2017Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
17.50
CY2017Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
17.50
CY2017Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1015848
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
23563014
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
0
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2013Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
234
CY2013Q4 dcth Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
7500000
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
18751000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
1227000
dcth Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Extinguishment Gain Loss Of Convertible Note Warrant
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExtinguishmentGainLossOfConvertibleNoteWarrant
17489000
CY2017Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
16000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1397
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21394
CY2013Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6900000
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
440
CY2015Q1 dcth Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
2600000
CY2015Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2500000
CY2015Q3 us-gaap Partners Capital Account Units Sale Of Units
PartnersCapitalAccountUnitsSaleOfUnits
1715
CY2015Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1715
CY2015Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6000000
CY2016Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1215
CY2016Q4 dcth Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
1200000
CY2016Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1100000
dcth Number Of Inputs Used For Valuation Of Warrants
NumberOfInputsUsedForValuationOfWarrants
6

Files In Submission

Name View Source Status
0001564590-17-023836-index-headers.html Edgar Link pending
0001564590-17-023836-index.html Edgar Link pending
0001564590-17-023836.txt Edgar Link pending
0001564590-17-023836-xbrl.zip Edgar Link pending
dcth-10q_20170930.htm Edgar Link pending
dcth-20170930.xml Edgar Link completed
dcth-20170930.xsd Edgar Link pending
dcth-20170930_cal.xml Edgar Link unprocessable
dcth-20170930_def.xml Edgar Link unprocessable
dcth-20170930_lab.xml Edgar Link unprocessable
dcth-20170930_pre.xml Edgar Link unprocessable
dcth-ex311_7.htm Edgar Link pending
dcth-ex312_8.htm Edgar Link pending
dcth-ex321_6.htm Edgar Link pending
dcth-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending